ВПЛИВ МОЛЕКУЛЯРНОГО ФЕНОТИПУ ПУХЛИНИ НА ВИЖИВАНІСТЬ ХВОРИХ НА РАК ШЛУНКА ПІСЛЯ РАДИКАЛЬНОГО ХІРУРГІЧНОГО ВТРУЧАННЯ

The strategy for the treatment of gastric cancer (GC), in particular the use of the extended surgical interventions in different countries varies. The different proportion of specific molecular GC subtypes in various populations frequently is not taken in...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2023
Автори: Dumanskyi, Yu.V., Kirkilevskyi, S.I., Sulaeva, O.M., Polyasnyi, V.O., Mashukov, A.O., Kovalevska, L.A., Yarema, R.R., Ogorchak, M.A.
Формат: Стаття
Мова:English
Опубліковано: PH Akademperiodyka 2023
Теми:
Онлайн доступ:https://exp-oncology.com.ua/index.php/Exp/article/view/2022-44-4-1
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Experimental Oncology

Репозитарії

Experimental Oncology
Опис
Резюме:The strategy for the treatment of gastric cancer (GC), in particular the use of the extended surgical interventions in different countries varies. The different proportion of specific molecular GC subtypes in various populations frequently is not taken into account for comparing treatment outcomes. This pilot study analyzes the association of survival of GC patients after the extended combined surgical interventions depending on the molecular subtype of the tumors. An improved survival for patients with diffuse cancer types (p53–, VEGFR+, HER2/neu+, Ki-67+ phenotype) was demonstrated. The authors propose their point of view on the importance of recognizing GC molecular heterogeneity.